Phenolic Acids as Antidepressant Agents

Nutrients. 2022 Oct 14;14(20):4309. doi: 10.3390/nu14204309.

Abstract

Depression is a psychiatric disorder affecting the lives of patients and their families worldwide. It is an important pathophysiology; however, the molecular pathways involved are not well understood. Pharmacological treatment may promote side effects or be ineffective. Consequently, efforts have been made to understand the molecular pathways in depressive patients and prevent their symptoms. In this context, animal models have suggested phytochemicals from medicinal plants, especially phenolic acids, as alternative treatments. These bioactive molecules are known for their antioxidant and antiinflammatory activities. They occur in some fruits, vegetables, and herbal plants. This review focused on phenolic acids and extracts from medicinal plants and their effects on depressive symptoms, as well as the molecular interactions and pathways implicated in these effects. Results from preclinical trials indicate the potential of phenolic acids to reduce depressive-like behaviour by regulating factors associated with oxidative stress, neuroinflammation, autophagy, and deregulation of the hypothalamic-pituitary-adrenal axis, stimulating monoaminergic neurotransmission and neurogenesis, and modulating intestinal microbiota.

Keywords: antiinflammatory; antioxidants; behaviour; depression; medicinal plants; phenolic compounds.

Publication types

  • Review

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use
  • Antioxidants* / chemistry
  • Antioxidants* / pharmacology
  • Antioxidants* / therapeutic use
  • Hypothalamo-Hypophyseal System
  • Pituitary-Adrenal System
  • Plant Extracts / pharmacology
  • Plants, Medicinal* / chemistry

Substances

  • Antioxidants
  • Antidepressive Agents
  • Plant Extracts
  • phenolic acid